Humane Genomics is a virus development platform that develops artificial viruses to cure diseases.
Humane Genomics has raised $4.0M in total funding. The most recent round was Seed. The last funding was announced in February 2025.
Humane Genomics's investors include Union Square Ventures, Y Combinator, Gaingels, SAV (Scale Asia Ventures), 2048 Ventures.
Humane Genomics is headquartered in New York, United States.
Humane Genomics is a virus development platform that develops artificial viruses to cure diseases.
Humane Genomics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Humane Genomics — Funding & Investors." VCBacked, February 12, 2025, https://www.vcbacked.co/company/humane-genomics. Accessed August 14, 2026.
VCBacked. (2025). Humane Genomics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/humane-genomics
{{cite web |title=Humane Genomics — Funding & Investors |url=https://www.vcbacked.co/company/humane-genomics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated